RUA Life Sciences plc (AIM:RUA)
24.55
+0.55 (2.29%)
Jul 27, 2026, 2:10 PM GMT
RUA Life Sciences Revenue
RUA Life Sciences had revenue of 2.75M GBP in the half year ending March 31, 2026, with 80.25% growth. This brings the company's revenue in the last twelve months to 4.62M, up 3.54% year-over-year. In the fiscal year ending September 30, 2025, RUA Life Sciences had annual revenue of 4.46M with 8.42% growth.
Revenue (ttm)
4.62M
Revenue Growth
+3.54%
P/S Ratio
3.29
Revenue / Employee
78.26K
Employees
59
Market Cap
15.20M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 4.46M | 346.34K | 8.42% |
| Mar 31, 2025 | 4.11M | 1.92M | 87.72% |
| Mar 31, 2024 | 2.19M | 12.00K | 0.55% |
| Mar 31, 2023 | 2.18M | 554.00K | 34.09% |
| Mar 31, 2022 | 1.63M | 97.00K | 6.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Inspiration Healthcare Group | 47.55M |
| Palatin Technologies | 9.76M |
| Cambridge Cognition Holdings | 9.40M |
| Fusion Antibodies | 1.60M |